INTERNATIONAL PATENT: NUVECTIS PHARMA, INC. FILES APPLICATION FOR "CRYSTALLINE SALT FORMS OF THE TYROSINE KINASE INHIBITOR ECF506"

GENEVA, May 19 -- NUVECTIS PHARMA, INC. (1 Bridge Plaza2nd FloorFort Lee, New Jersey 07024) filed a patent application (PCT/US2024/055089) for "CRYSTALLINE SALT FORMS OF THE TYROSINE KINASE INHIBITOR ECF506" on Nov 08, 2024. With publication no. WO/2025/101874, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HANSEN, Marcus (c/o NUVECTIS PHARMA, INC.1 Bridge Plaza2nd FloorFort Lee, New Jersey 07024), SENTISSI, Abdellah (c/o NUVECTIS PHARMA, INC.1 Bridge Plaza2nd FloorFort Lee, New Jersey 07024), SHEMESH, Shay (c/o NUVECTIS...